Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Phase I first-in-human study of CUDC-101, a multitargeted inhibitor of HDACs, EGFR, and HER2 in patients with advanced solid tumors.

Shimizu T, LoRusso PM, Papadopoulos KP, Patnaik A, Beeram M, Smith LS, Rasco DW, Mays TA, Chambers G, Ma A, Wang J, Laliberte R, Voi M, Tolcher AW.

Clin Cancer Res. 2014 Oct 1;20(19):5032-40. doi: 10.1158/1078-0432.CCR-14-0570. Epub 2014 Aug 8.

2.

Sustaining cardiac claudin-5 levels prevents functional hallmarks of cardiomyopathy in a muscular dystrophy mouse model.

Delfín DA, Xu Y, Schill KE, Mays TA, Canan BD, Zang KE, Barnum JA, Janssen PM, Rafael-Fortney JA.

Mol Ther. 2012 Jul;20(7):1378-83. doi: 10.1038/mt.2012.81. Epub 2012 May 1.

3.

The clinical effect of the dual-targeting strategy involving PI3K/AKT/mTOR and RAS/MEK/ERK pathways in patients with advanced cancer.

Shimizu T, Tolcher AW, Papadopoulos KP, Beeram M, Rasco DW, Smith LS, Gunn S, Smetzer L, Mays TA, Kaiser B, Wick MJ, Alvarez C, Cavazos A, Mangold GL, Patnaik A.

Clin Cancer Res. 2012 Apr 15;18(8):2316-25. doi: 10.1158/1078-0432.CCR-11-2381. Epub 2012 Jan 19.

4.

Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

Rafael-Fortney JA, Chimanji NS, Schill KE, Martin CD, Murray JD, Ganguly R, Stangland JE, Tran T, Xu Y, Canan BD, Mays TA, Delfín DA, Janssen PM, Raman SV.

Circulation. 2011 Aug 2;124(5):582-8. doi: 10.1161/CIRCULATIONAHA.111.031716. Epub 2011 Jul 18.

5.

Glutamate receptors localize postsynaptically at neuromuscular junctions in mice.

Mays TA, Sanford JL, Hanada T, Chishti AH, Rafael-Fortney JA.

Muscle Nerve. 2009 Mar;39(3):343-9. doi: 10.1002/mus.21099.

6.

Truncated CASK does not alter skeletal muscle or protein interactors.

Sanford JL, Mays TA, Varian KD, Wilson JB, Janssen PM, Rafael-Fortney JA.

Muscle Nerve. 2008 Sep;38(3):1116-27. doi: 10.1002/mus.20993.

PMID:
18642383
7.

Claudin-5 levels are reduced in human end-stage cardiomyopathy.

Mays TA, Binkley PF, Lesinski A, Doshi AA, Quaile MP, Margulies KB, Janssen PM, Rafael-Fortney JA.

J Mol Cell Cardiol. 2008 Jul;45(1):81-7. doi: 10.1016/j.yjmcc.2008.04.005. Epub 2008 Apr 25.

PMID:
18513742
8.

Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice.

Janssen PM, Hiranandani N, Mays TA, Rafael-Fortney JA.

Am J Physiol Heart Circ Physiol. 2005 Dec;289(6):H2373-8. Epub 2005 Jul 15.

9.

CASK localizes to nuclei in developing skeletal muscle and motor neuron culture models and is agrin-independent.

Gardner KL, Sanford JL, Mays TA, Rafael-Fortney JA.

J Cell Physiol. 2006 Jan;206(1):196-202.

PMID:
15965905
10.

Claudin-5 localizes to the lateral membranes of cardiomyocytes and is altered in utrophin/dystrophin-deficient cardiomyopathic mice.

Sanford JL, Edwards JD, Mays TA, Gong B, Merriam AP, Rafael-Fortney JA.

J Mol Cell Cardiol. 2005 Feb;38(2):323-32. Epub 2005 Jan 22.

PMID:
15698839
11.

CASK and Dlg form a PDZ protein complex at the mammalian neuromuscular junction.

Sanford JL, Mays TA, Rafael-Fortney JA.

Muscle Nerve. 2004 Aug;30(2):164-71.

PMID:
15266631
12.

Antidepressants in the management of cancer pain.

Mays TA.

Curr Pain Headache Rep. 2001 Jun;5(3):227-36. Review.

PMID:
11309210

Supplemental Content

Support Center